Please Wait
Applying Filters...
menu
    • menu
    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-01-20

    Virtual Booth

    Contact Supplier

    Menu

    TT-00420

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    TransThera: Tinengotinib Solid Tumor Data
    TransThera: Tinengotinib Solid Tumor Data

    12 Apr 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/2024-aacr-late-breaking-researchtransthera-announces-clinical-data-of-tinengotinib-to-treat-patients-with-advanced-solid-tumors-harboring-actionable-fgfr1-3-alterations-302115397.html

    PR NEWSWIRE
    12 Apr 2024
    Share Share
    TransThera Announces Phase 3 Completed First Patient Dosing Evaluating Tinengotinib
    TransThera Announces Phase 3 Completed First Patient Dosing Evaluating Tinengotinib

    21 Dec 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/transthera-announces-the-global-multicenter-phase-3-clinical-trial-completed-first-patient-dosing-in-the-us-evaluating-tinengotinib-in-fgfri-relapsedrefractory-patients-with-cholangiocarcinoma-302021004.html

    PR NEWSWIRE
    21 Dec 2023
    Share Share
    TransThera announces an oral presentation of tinengotinib data in breast cancer
    TransThera announces an oral presentation of tinengotinib data in breast cancer

    07 Dec 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/2023-sabcs---transthera-announces-an-oral-presentation-of-tinengotinib-clinical-data-in-breast-cancer-302008583.html

    PR NEWSWIRE
    07 Dec 2023
    Share Share
    TransThera announces two oral presentations of tinengotinib clinical data
    TransThera announces two oral presentations of tinengotinib clinical data

    09 Oct 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/transthera-announces-two-oral-presentations-of-tinengotinib-clinical-data-at-2023-esmo-and-sabcs-annual-meetings-301950709.html

    PR NEWSWIRE
    09 Oct 2023
    Share Share